Search Results - Jean-Louis Lefèbvre
- Showing 1 - 8 results of 8
-
1
Current clinical outcomes demand new treatment options for SCCHN by Jean Louis Lefèbvre
Published 2005Revisão -
2
Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma by C. Domenge, Catherine Hill, Jean Louis Lefèbvre, D. De Raucourt, B. Rhein, P. Wibault, P Marandas, Bernard Coche‐Dequeant, M Stromboni-Luboinski, H Sancho-Garnier, B Luboïnski
Published 2000Artigo -
3
Postoperative Irradiation with or without Concomitant Chemotherapy for Locally Advanced Head and Neck Cancer by Jacques Bernier, C. Domenge, Mahmut Özsahin, Katarzyna Łukawska‐Matuszewska, Jean-Louis Lefèbvre, Richard Greiner, J. Giralt, P. Maingon, Frédéric Rolland, M. Bolla, F. Cognetti, Jean Bourhis, Anne Kirkpatrick, M. van Glabbeke
Published 2004Artigo -
4
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer by Jan B. Vermorken, Éva Remenár, Carla van Herpen, Thierry Gorlia, Ricard Mesı́a, M. Degardin, John S. Stewart, S. Jelić, Jan Betka, Joachim H. Preiss, Daniëlle Van den Weyngaert, Ahmad Awada, Didier Cupissol, H. Kienzer, A Rey, Isabelle Desaunois, Jacques Bernier, Jean-Louis Lefèbvre
Published 2007Artigo -
5
Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy by Jean Louis Lefèbvre, Frédéric Rolland, Margot Tesselaar, É. Bardet, C. René Leemans, Lionnel Geoffrois, P. Hupperets, Luigi Barzan, D. De Raucourt, Dominique Chevalier, Lisa Licitra, F Lunghi, Roger Stupp, Denis Lacombe, Jan Bogaerts, Jean-Claude Horiot, J. Bernier, Jan B. Vermorken
Published 2009Artigo -
6
Planned neck dissection following chemoradiotherapy for advanced head and neck cancer: Is it necessary for all? by Phillip K. Pellitteri, Alfio Ferlito, Alessandra Rinaldo, Jatin P. Shah, Randal S. Weber, John Lowry, Jesús E. Medina, Christine G. Gourin, K. Thomas Robbins, Carlos Suárez, Ashok R. Shaha, Eric M. Genden, C. René Leemans, Jean Louis Lefèbvre, Luiz Paulo Kowalski, WI Wei
Published 2005Revisão -
7
Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study by Jean Louis Lefèbvre, Y. Pointreau, Frédéric Rolland, M. Alfonsi, A Baudoux, C. Sire, D. De Raucourt, O. Malard, M. Degardin, C. Tuchais, Emmanuel Blot, M. Rives, Émile Reyt, Jean Marc Tourani, L. Geoffrois, Fréderic Peyrade, F. Guichard, Dominique Chevalier, E. Babin, Philippe Lang, François Janot, G. Calais, P. Garaud, É. Bardet
Published 2013Artigo -
8
American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer by David G. Pfister, Scott A. Laurie, Gregory S. Weinstein, William M. Mendenhall, David J. Adelstein, K. Kian Ang, Gary L. Clayman, Susan G. Fisher, Arlene A. Forastiere, Louis B. Harrison, Jean‐Louis Lefebvre, Nancy E. Leupold, Marcy A. List, Bernard O’Malley, Snehal G. Patel, Marshall R. Posner, Michael Schwartz, Gregory T. Wolf
Published 2006Revisão
Search Tools:
Related Subjects
Internal medicine
Medicine
Surgery
Cancer
Chemotherapy
Radiation therapy
Oncology
Randomized controlled trial
Cisplatin
Fluorouracil
Head and neck cancer
Induction chemotherapy
Larynx
Chemoradiotherapy
Clinical trial
Concomitant
Disease
Docetaxel
Head and neck
Laryngectomy
Pathology
Alternative medicine
Biology
Cetuximab
Clinical endpoint
Colorectal cancer
Dissection (medical)
Guideline
Intensive care medicine
Multidisciplinary approach